PVT1 promotes resistance to 5-FU in colon cancer via the miR-486-5p/CDK4 axis

Drug resistance in tumors is a major issue, limiting the curative efficacy of currently available cancer chemotherapeutics. 5-Fluorouracil (5-FU) is a commonly applied therapeutic drug in colon cancer patient regimens; however, the majority of patients develop resistance to 5-FU in the later stages...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Zhuhe, Chen, Ruijun, Hu, Shen, Huang, Xibin, Huang, Zhenyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260730/
https://www.ncbi.nlm.nih.gov/pubmed/35814832
http://dx.doi.org/10.3892/ol.2022.13400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260730/
https://www.ncbi.nlm.nih.gov/pubmed/35814832
http://dx.doi.org/10.3892/ol.2022.13400

Ejemplares similares